AU509084B2 - l-(2'aroyl eth-1' yl)-2-(4-acetamido piperazine-l-yl methyl) benzimidoles - Google Patents

l-(2'aroyl eth-1' yl)-2-(4-acetamido piperazine-l-yl methyl) benzimidoles

Info

Publication number
AU509084B2
AU509084B2 AU10117/76A AU1011776A AU509084B2 AU 509084 B2 AU509084 B2 AU 509084B2 AU 10117/76 A AU10117/76 A AU 10117/76A AU 1011776 A AU1011776 A AU 1011776A AU 509084 B2 AU509084 B2 AU 509084B2
Authority
AU
Australia
Prior art keywords
benzimidoles
eth
aroyl
acetamido
piperazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU10117/76A
Other versions
AU1011776A (en
Inventor
C. Turin M. Imbert T. Raynaud G. and Dorme M Fauran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Delalande SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7500724A external-priority patent/FR2297045A1/en
Priority claimed from FR7537297A external-priority patent/FR2333510A2/en
Application filed by Delalande SA filed Critical Delalande SA
Publication of AU1011776A publication Critical patent/AU1011776A/en
Application granted granted Critical
Publication of AU509084B2 publication Critical patent/AU509084B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/10—Radicals substituted by halogen atoms or nitro radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU10117/76A 1975-01-10 1976-01-08 l-(2'aroyl eth-1' yl)-2-(4-acetamido piperazine-l-yl methyl) benzimidoles Expired AU509084B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR7500724A FR2297045A1 (en) 1975-01-10 1975-01-10 NEW (AROYL-2 'ETH-1' YL) -1 (ACETAMIDO-4 '' PIPERAZIN-1 '' YL METHYL) -2 BENZIMIDAZOLES WITH GASTRIC AND ANTIULCEROUS ANTI-SECRETORY PROPERTIES
FRFR75.00724 1975-01-10
FR7537297A FR2333510A2 (en) 1975-12-05 1975-12-05 1-Aroylethyl 2-piperazinomethyl benzimidazoles - useful eg for treatment of ulcers, asthma, hypertension, oedemand pain
FRFR75.37297 1975-12-05

Publications (2)

Publication Number Publication Date
AU1011776A AU1011776A (en) 1977-07-14
AU509084B2 true AU509084B2 (en) 1980-04-17

Family

ID=26218682

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10117/76A Expired AU509084B2 (en) 1975-01-10 1976-01-08 l-(2'aroyl eth-1' yl)-2-(4-acetamido piperazine-l-yl methyl) benzimidoles

Country Status (13)

Country Link
JP (1) JPS6020386B2 (en)
AU (1) AU509084B2 (en)
CA (1) CA1073455A (en)
CH (1) CH612675A5 (en)
DE (1) DE2557446C2 (en)
ES (1) ES444064A1 (en)
GB (1) GB1487128A (en)
IT (1) IT1062803B (en)
LU (1) LU74043A1 (en)
MX (1) MX3428E (en)
NL (1) NL7600224A (en)
SE (1) SE421527B (en)
SU (1) SU651701A3 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2190439B1 (en) * 1972-07-06 1975-06-20 Delalande Sa

Also Published As

Publication number Publication date
ES444064A1 (en) 1977-08-16
IT1062803B (en) 1985-02-11
JPS6020386B2 (en) 1985-05-21
JPS51131885A (en) 1976-11-16
SE421527B (en) 1982-01-04
SE7600116L (en) 1976-07-12
LU74043A1 (en) 1976-11-11
CA1073455A (en) 1980-03-11
MX3428E (en) 1980-11-21
AU1011776A (en) 1977-07-14
GB1487128A (en) 1977-09-28
DE2557446C2 (en) 1984-11-29
SU651701A3 (en) 1979-03-05
CH612675A5 (en) 1979-08-15
NL7600224A (en) 1976-07-13
DE2557446A1 (en) 1976-07-15

Similar Documents

Publication Publication Date Title
GB2036010B (en) 4-((3,4-dialkoxyhenyl)-alkyl)-2-imidazolidinone derivatives and processes for the preparation thereof
NL7709812A (en) PROCESS FOR PREPARING 6 (D- (ALPHA) -AMINO-P-HY-DROXYPHENYLACETAMIDO) PENICILLAN ACID.
AU521741B2 (en) N-(diaminophosphinyl)arylcarboxamides
NZ186991A (en) 2-(omega,omega-diarylalkyl)-1-azabicyclo(2,2,2)octane derivatives and pharmaceutical compositions
NL7607325A (en) SAILMAST FOR SAILSKIS.
DE2962423D1 (en) Solid stable pharmaceutical composition on the basis of a 1,3-diester of 17-alpha-ethynyl-7-alpha-methyl-1,3,5(10)-estratriene-1,3,17-beta-triol
AU506432B2 (en) 4 ((4 Diphenylmethyl) l-piperidinyl)methyl) benzenamines
AU517792B2 (en) 1, 2, 3-thiadiazol-3-in-5-ylidine ureas
AU506052B2 (en) Preparation of 2-(2, 2-dicyclohexylethyl) piperidine
NL7810456A (en) PROCEDURE FOR PREPARING 6,11-DIHYDRO-11-OXODI-BENZ (B, E) -OXEPINE-2-ACETIC ACID AND INTERMEDIATES.
AU516765B2 (en) 1, 3-disubstituted (2-thio) ureas
AU516505B2 (en) 1-(mono-o-substituted benzoyl)-3-(substituted pyrazinyl) ureas and preparations
AU509084B2 (en) l-(2'aroyl eth-1' yl)-2-(4-acetamido piperazine-l-yl methyl) benzimidoles
AU500164B2 (en) 3, 4, 5-substituted benzenesulfonformamidines
AU4910179A (en) 2-phenyl-amino-imidazoline (2) derivatives possessing bradycardiac activity
NL7706640A (en) PROCESS FOR THE PREPARATION OF 2,9-DIOXATRI-CYCLO (4,3,1,03,7) DECANS.
AU501305B2 (en) N'sulfonyl-n-dihalophenylimidazolidinedioners
AU519127B2 (en) N-(1, 3, 4-thiadiazol-2-7l) benzamides
PH13909A (en) 17(-acetylenic-androstenes,the pharmaceutical composition
PH15812A (en) Process for the preparation of 1-(2-tetrahydrofuryl)5-fluorouracil
NL7811876A (en) EXCIPIENT COMPOSITION FOR CREAMS.
ZA793178B (en) Sulfonyl ureas,process for their manufacture,pharmaceutical preparations on the basis of these compounds and their use
SU648471A1 (en) Container
AU515232B2 (en) A-nor-androsta-3(5)16 dien-2-ones
IL56280A0 (en) Pharmaceutical compositions containing cis-(3,3,5)-trimethylcyclohexanol and methods for the use thereof